Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 20 | 2026 | 913 | 3.170 |
Why?
|
| Mammography | 8 | 2026 | 141 | 2.190 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2021 | 107 | 1.100 |
Why?
|
| Breast Density | 2 | 2026 | 24 | 1.010 |
Why?
|
| Adipose Tissue | 1 | 2026 | 63 | 0.960 |
Why?
|
| Mastectomy, Segmental | 3 | 2021 | 15 | 0.790 |
Why?
|
| Contrast Media | 5 | 2021 | 10 | 0.730 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2013 | 222 | 0.640 |
Why?
|
| Retrospective Studies | 14 | 2026 | 2463 | 0.610 |
Why?
|
| Neoadjuvant Therapy | 5 | 2021 | 12 | 0.560 |
Why?
|
| Female | 22 | 2026 | 12193 | 0.490 |
Why?
|
| Biopsy | 4 | 2017 | 74 | 0.480 |
Why?
|
| Humans | 26 | 2026 | 16832 | 0.460 |
Why?
|
| Trauma Centers | 1 | 2015 | 6 | 0.440 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 26 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 43 | 0.420 |
Why?
|
| Breast | 5 | 2023 | 66 | 0.390 |
Why?
|
| Sensitivity and Specificity | 5 | 2026 | 291 | 0.390 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 393 | 0.370 |
Why?
|
| Early Detection of Cancer | 4 | 2026 | 553 | 0.360 |
Why?
|
| Middle Aged | 14 | 2026 | 7515 | 0.360 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 1 | 0.340 |
Why?
|
| Aged | 12 | 2026 | 5901 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 203 | 0.280 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2026 | 515 | 0.280 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 319 | 0.260 |
Why?
|
| Ultrasonography, Mammary | 2 | 2018 | 4 | 0.250 |
Why?
|
| Palpation | 1 | 2026 | 9 | 0.240 |
Why?
|
| Germ-Line Mutation | 1 | 2026 | 17 | 0.240 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 19 | 0.230 |
Why?
|
| Precision Medicine | 1 | 2025 | 28 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 12 | 0.220 |
Why?
|
| Image Enhancement | 2 | 2021 | 3 | 0.200 |
Why?
|
| Hydronephrosis | 1 | 2023 | 2 | 0.190 |
Why?
|
| Ureteral Calculi | 1 | 2023 | 2 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 26 | 0.190 |
Why?
|
| Adult | 11 | 2026 | 7255 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2023 | 2396 | 0.190 |
Why?
|
| Algorithms | 1 | 2023 | 210 | 0.170 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 79 | 0.170 |
Why?
|
| Neodymium | 1 | 2020 | 1 | 0.160 |
Why?
|
| Magnetic Phenomena | 1 | 2020 | 1 | 0.160 |
Why?
|
| HIV Infections | 1 | 2026 | 708 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2019 | 2 | 0.150 |
Why?
|
| Prospective Studies | 4 | 2020 | 1186 | 0.150 |
Why?
|
| Echo-Planar Imaging | 1 | 2019 | 1 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 46 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 189 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2023 | 325 | 0.140 |
Why?
|
| Telemedicine | 1 | 2022 | 190 | 0.140 |
Why?
|
| Foreign Bodies | 1 | 2018 | 1 | 0.140 |
Why?
|
| Surgical Instruments | 1 | 2018 | 2 | 0.140 |
Why?
|
| Parenchymal Tissue | 1 | 2017 | 1 | 0.130 |
Why?
|
| Radiologists | 1 | 2016 | 6 | 0.120 |
Why?
|
| Calcinosis | 1 | 2016 | 18 | 0.120 |
Why?
|
| Risk Factors | 3 | 2025 | 3108 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 42 | 0.120 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 322 | 0.120 |
Why?
|
| Utilization Review | 1 | 2015 | 33 | 0.110 |
Why?
|
| Boston | 1 | 2015 | 31 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 41 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 1887 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 317 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2021 | 1098 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 15 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 242 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2023 | 995 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 989 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 346 | 0.060 |
Why?
|
| BRCA1 Protein | 1 | 2026 | 7 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2026 | 63 | 0.060 |
Why?
|
| Young Adult | 2 | 2021 | 2456 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 1233 | 0.050 |
Why?
|
| Reoperation | 1 | 2021 | 24 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 6 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2025 | 1047 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 78 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 45 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 76 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 35 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 289 | 0.040 |
Why?
|
| Angiography | 1 | 2019 | 9 | 0.040 |
Why?
|
| Rivaroxaban | 1 | 2019 | 8 | 0.040 |
Why?
|
| Factor Xa Inhibitors | 1 | 2019 | 10 | 0.040 |
Why?
|
| California | 1 | 2026 | 2244 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 16 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2019 | 9 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 130 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2019 | 15 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2019 | 33 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 69 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 94 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 103 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 152 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 1229 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 34 | 0.030 |
Why?
|
| Health Facilities | 1 | 2016 | 16 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2016 | 107 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1430 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 449 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 52 | 0.030 |
Why?
|
| Male | 2 | 2021 | 9556 | 0.030 |
Why?
|
| Iopamidol | 1 | 2012 | 1 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2012 | 1 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 5 | 0.020 |
Why?
|
| Software | 1 | 2012 | 18 | 0.020 |
Why?
|
| Mass Screening | 1 | 2017 | 670 | 0.020 |
Why?
|
Concepts
(109)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->